HDAC9 and malaria: There have been reports of selectivity of some HDAC inhibitors for malaria parasites versus mammalian cell lines (for example, Andrews et al., 2008, Dow et al., 2008, Wheatley et al., 2010), highlighting the potential to design inhibitors to selectively target non-mammalian HDAC enzymes.